Odonate Therapeutics, Inc.
ODTC · OTC
12/31/2022 | 9/30/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | 4,330.567 | 36,349.698 | 1,287.871 | -9,841.349 |
| % Growth | -88.1% | 2,722.5% | 113.1% | – |
| Operating Cash Flow | $0 | – | -$0 | -$0 |
| Capital Expenditures | $0 | – | $0 | $0 |
| Free Cash Flow | $0 | – | -$0 | -$0 |